1. AstraZeneca
2. Roche
3. Bristol-Myers Squibb
4. Johnson & Johnson
5. Merck
6. Pfizer
7. AbbVie
8. Novartis
9. GlaxoSmithKline
10. Takeda
The competitive landscape in the Ovarian Cancer Drugs Market is intensifying with key players focusing on research and development activities to launch innovative treatment options. Emerging companies are also entering the market with novel therapies, further increasing competition in the industry.